ProCE Banner Activity

Using PD-L1 to Guide Therapy in the Clinic

Slideset Download
In this downloadable slideset, Giuseppe Giaccone, MD, PhD, discusses the current data on using PD-L1 status to select patients for treatment with immune checkpoint inhibitors in solid tumors.

Released: May 31, 2019

Expiration: May 29, 2020

No longer available for credit.

Share

Faculty

Giuseppe Giaccone

Giuseppe Giaccone, MD, PhD

Chief, Medical Oncology Branch
CCR, National Cancer Institute
Bethesda, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Foundation Medicine

Genentech TEXT Only

Loxo Oncology

Merck Oncology

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Giuseppe Giaccone, MD, PhD

Chief, Medical Oncology Branch
CCR, National Cancer Institute
Bethesda, Maryland